Heart Valve Technology

This channel includes news and new device innovations about heart valve technologies, including the aortic valve, mitral valve, pulmonic valve, and tricuspid valve. This includes information on transcatheter valve technologies like transcatheter aortic valve replacement (TAVR, or implantation TAVI), transcatheter mitral valve repair or replacement (TMVR), transcatheter and surgical valve repairs, and surgical replacement valves. Newer devices are now being used for transcatheter tricuspid valve repair replacement (TTVR).

Investigational technology designed for patients undergoing emerging large bore percutaneous catheter-based venous interventional procedures

News | Vascular Closure Devices

Vivasure Medical Announces First Large Hole Venous Patient Treated with PerQseal Elite Vascular Closure System

April 16, 2024 — Vivasure Medical, a company pioneering novel fully absorbable technology for percutaneous vessel ...

April 16, 2024

UC Davis is one of the first sites nationwide to treat tricuspid regurgitation using a minimally invasive catheter system

News | Structural Heart

Cardiology Team Performs Novel Heart Artery Repair with Newly Approved Device

April 9, 2024 — UC Davis Health cardiology team members are among the first in the country to treat patients with tricus ...

April 09, 2024

Trial shows increased risk of bleeding with topical administration during open heart surgery

News | Cardiovascular Clinical Studies

Topical Tranexamic Acid Found Inferior to Intravenous Administration

April 9, 2024 — Administering tranexamic acid (TxA), a drug used to reduce bleeding during heart surgery, topically ...

April 09, 2024

First head-to-head comparison of leading valve types finds better valve performance with selfexpanding valve and non-inferior clinical outcomes at one year

News | Cardiovascular Clinical Studies

Self-Expanding Valve Outperforms Balloon-Expandable Valve for TAVR in Patients with Small Valve Annulus

April 9, 2024 — People with a small aortic annulus, a part of the heart’s anatomy where the left ventricle meets the ...

April 09, 2024

Mechanical circulatory support boosts survival in cardiogenic shock patients, despite risks

News | Cardiovascular Clinical Studies

Heart Pump Improves Survival After Severe Heart Attacks

April 8, 2024 — Implantation of the Impella CP micro-axial flow pump in the hours after a heart attack significantly ...

April 08, 2024

Abbott has announced U.S Food and Drug Administration (FDA) approval of its TriClip, a first-of-its-kind device to repair leaky tricuspid heart valve.

News | FDA

Abbott Announces FDA Approval of First-of-its-kind Device to Repair Leaky Tricuspid Heart Valve, TriClip

April 2, 2024 — Abbott announced that the U.S. Food and Drug Administration (FDA) approved the company's first-of-its ...

April 02, 2024

Roughly 25,000 Americans die each year from valvular heart disease, but researchers from Rutgers Health and other institutions conclude that new technology could soon help doctors slash that number

News | Heart Valve Technology

New Technology Promises to Revolutionize Valvular Heart Disease Care

April 1, 2024 — Roughly 25,000 Americans die each year from valvular heart disease, but researchers from Rutgers Health ...

April 01, 2024

The academic medical centers earned distinguished three-star ratings from The Society of Thoracic Surgeons (STS) for their patient care and outcomes in adult cardiac surgery

News | Cardiovascular Surgery

Hackensack Meridian Hackensack University and Jersey Shore University Medical Centers Again Ranked Among the Elite Hospitals in North America for Open Heart Surgery

February 26, 2024 — Hackensack Meridian Jersey Shore University Medical Center and Hackensack University Medical Center ...

February 26, 2024

The DAIC team has learned of the passing of Alain Cribier, MD, FACC, heralded as the man who pioneered the first transcatheter aortic valve replacement (TAVR) in 2002

Feature | Cardiovascular Surgery

In Memoriam: Alain Cribier, MD, FACC, TAVR Pioneer

The DAIC team has learned of the passing of Alain Cribier, MD, FACC, heralded as the man who pioneered the first transca ...

February 23, 2024

The EVOQUE system is indicated for the improvement of health status in patients with symptomatic severe TR despite optimal medical therapy (OMT), for whom tricuspid valve replacement is deemed appropriate by a heart team.

News | FDA

Edwards’ EVOQUE Valve Replacement System First Transcatheter Therapy Earns FDA Approval for Tricuspid Valve

February 2, 2024 — Edwards Lifesciences Corporation announced the company’s EVOQUE tricuspid valve replacement system is ...

February 02, 2024

The Smidt Heart Institute recently received CAROL Act funding to study the connection between ventricular arrhythmias-abnormal heartbeats that start in the heart’s two lower chambers-and an elevated risk of sudden cardiac death in patients with mitral valve disease

Feature

Spotlight on Advancements in Mitral Valve Repair, Research

You may not know Carol Barr, but in the future, she could save your life.

Barr’s death at 39 from sudden cardiac ...

January 24, 2024

Five implants successfully accomplished at the Instituto Nacional de Torax in Santiago, Chile with advanced engineered heart valve, ZETA, designed to provide flexibility and optionality regardless of high, low or zero calcification

News | Structural Heart

Laguna Tech USA Announces Site Record Number of Transcatheter Heart Valves Implanted at Single Center on Same Day in First-in-Human Clinical Trial

January 4, 2024 — Laguna Tech USA, a privately-held medical technology company dedicated to innovations in structural ...

January 04, 2024

Study investigators Drs. Pedro Engel-Gonzalez and Gennaro Giustino from Henry Ford Health.

News | Heart Valve Technology

Henry Ford Health Cardiologists Publish Case Series Study on Heart Valve Procedure

January 4, 2024 — Findings from a published case series research letter by the Henry Ford Health Structural Heart ...

January 04, 2024

TRiCares SAS (“TRiCares”), a privately held pioneer in the field of minimally invasive treatment of tricuspid regurgitation, announced the successful implantation of its Topaz transfemoral tricuspid heart valve replacement system (“Topaz”) in a patient with a pacemaker at the University Medical Center of Mainz, Germany.

News | Heart Valve Technology

TRiCares Announces Successful Implantation of Minimally Invasive Topaz Tricuspid Heart Valve Replacement System in Patient with a Pacemaker

December 22, 2023 — TRiCares SAS (“TRiCares”), a privately held pioneer in the field of minimally invasive treatment of ...

December 22, 2023

Substance use disorder may be linked to more deaths from infective endocarditis among people ages 25-44, finds new study in Journal of the American Heart Association

News | Heart Valve Technology

Deaths from Heart Valve Infections Drop Across US Overall, but Surged Among Young Adults

December 18, 2023 — Death rates related to infective endocarditis declined in most adults across the U.S. within the ...

December 18, 2023